Location History:
- Ramlinsburg, CH (2016 - 2017)
- Ramlinsburg BL, CH (2015 - 2018)
- Ramlingsburg BL, CH (2018)
Company Filing History:
Years Active: 2015-2018
Title: **The Innovative Contributions of Dieter Haag**
Introduction
Dieter Haag, an accomplished inventor based in Ramlinsburg, Switzerland, has made significant strides in the field of pharmaceuticals through his innovative inventions. With a total of five patents to his name, he has contributed to the development of pharmaceutical compounds that enhance stability and efficiency in medical formulations.
Latest Patents
One of Dieter Haag's notable inventions is the crystalline mono mesylate monohydrate salt of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide. This invention features a specific particle size distribution range and surface area range, which have shown to significantly improve the long-term stability and release kinetics of pharmaceutical formulations. The invention also delves into the pharmacokinetic and pharmacodynamic profiles of the resulting free base after administration, demonstrating its potential for treating subjects in need.
Career Highlights
Throughout his career, Dieter Haag has worked with esteemed companies in the pharmaceutical industry, such as Aicuris Anti-infective Cures GmbH and Aicuris GmbH & Co. KG. His expertise and discoveries have led to advancements in drug development, emphasizing the importance of effective pharmaceutical compositions.
Collaborations
Dieter Haag has collaborated with several professionals in the industry, including Wilfried Schwab and Alexander Birkmann. These collaborations have played a pivotal role in shaping his innovative projects and furthering research in pharmaceutical technologies.
Conclusion
Dieter Haag's contributions stand as a testament to the power of innovation in the pharmaceutical field. His patented inventions not only enhance the stability and effectiveness of medications but also pave the way for future research and development in the industry. As he continues to push boundaries, Dieter Haag remains a key figure in the world of pharmaceutical innovation.